Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results.
暂无分享,去创建一个
M. Blumenkranz | J. Haller | A. Loewenstein | M. Gillies | S. Whitcup | F. Bandello | J. Heier | Y. Yoon | R. Belfort | Jenny Jiao | Xiao-Yan Li | Joanne Li | J. Jiao | Y. Yoon
[1] M. Blumenkranz,et al. Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. , 2010, Ophthalmology.
[2] P. Campochiaro,et al. Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study. , 2010, Ophthalmology.
[3] Sarah Gray,et al. Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study. , 2010, Ophthalmology.
[4] Ingrid U Scott,et al. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5. , 2009, Archives of ophthalmology.
[5] Matus Rehak,et al. Branch Retinal Vein Occlusion: Pathogenesis, Visual Prognosis, and Treatment Modalities , 2008, Current eye research.
[6] K. Eng,et al. RANDOMIZED CONTROLLED STUDY OF AN INTRAVITREOUS DEXAMETHASONE DRUG DELIVERY SYSTEM IN PATIENTS WITH PERSISTENT MACULAR EDEMA , 2007 .
[7] George A. Williams,et al. Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema. , 2007, Archives of ophthalmology.